Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06599502 |
| Title | A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation (ALAFOSS-01) |
| Acronym | ALAFOSS-01 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Duarte | California | 91010 | United States | Details | |
| Research Site | New York | New York | 10016 | United States | Details | |
| Research Site | Fairfax | Virginia | 22031 | United States | Details | |
| Research Site | Melbourne | 3000 | Australia | Details | ||
| Research Site | Tokyo | 104-0045 | Japan | Details | ||
| Research Site | Seoul | 03080 | South Korea | Details |